The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study
Open accessAbstract
Background— The long-term safety of drug-eluting stents (DES) for acute myocardial infarction (AMI) remains uncertain. Using autopsy data, we evaluated the pathological responses of the stented segment in patients treated with DES for AMI and compared with patients with stable angina. Methods and Results— From the CVPath Registry of 138 DES autopsies, we identified 25 patients who presented with AMI and had an underlying necrotic core with a ruptured fibrous cap. Twenty-six patients who had stable angina with thick-cap fibroatheroma treated by DES were selected as controls. Histomorphometric analysis was performed in patients with >30-day stent duration. We compared the response to stenting at the culprit site in these 2 groups and to nonculprit sites within each stent. Late stent thrombosis was significantly less frequent in stable (11%) than in AMI (41%; P =0.04) patients. Although neointimal thickness in the AMI culprit site was significantly less (median, 0.04 mm; interquartile range [IQR], 0.02 to 0.09 mm), the prevalence of uncovered struts (49%; IQR, 16% to 96%), fibrin deposition (63±28%), and inflammation (35%; IQR, 27% to 49%) were significantly greater compared with the culprit site in stable patients (neointimal thickness: 0.11 mm [IQR, 0.07 to 0.21 mm], P =0.008; uncovered struts: 9% [IQR, 0% to 39%], P =0.01; fibrin: 36±27%, P =0.008; inflammation, 17% [IQR, 7% to 25%], P =0.003) and the nonculprit site within each stent. Conclusions— Vessel healing at the culprit site in AMI patients treated with DES is substantially delayed compared with the culprit site in patients receiving DES for stable angina, emphasizing the importance of underlying plaque morphology in the arterial response to DES. Our data suggest an increased risk of thrombotic complications in patients treated with DES for AMI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
Self-citationIakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Self-citationDaemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Jüni, P., Sianos, G., Hellige, G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60314-6 · Cited by 1,757
Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly
Burke, A. P., Farb, A., Malcom, G. T., Liang, Y.-H., Smialek, J., & Virmani, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361802 · Cited by 1,745
Self-citationSafety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
Stone, G. W., Moses, J. W., Ellis, S. G., Schofer, J., Dawkins, K. D., Morice, M.-C., Colombo, A., Schampaert, E., Grube, E., Kirtane, A. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067193 · Cited by 1,631
Finn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Self-citationLong-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
Lagerqvist, B., James, S. K., Stenestrand, U., Lindbäck, J., Nilsson, T., & Wallentin, L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067722 · Cited by 1,197
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
Finn, A. V., Nakazawa, G., Joner, M., Kolodgie, F. D., Mont, E. K., Gold, H. K., & Virmani, R. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144220 · Cited by 900
Self-citationIncomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
Cook, S., Wenaweser, P., Togni, M., Billinger, M., Morger, C., Seiler, C., Vogel, R., Hess, O., Meier, B., & Windecker, S. (2007) · Circulation · doi:10.1161/circulationaha.106.658237 · Cited by 839
Geng, Y., & Libby, P. (1995) · Europe PMC (PubMed Central) · Cited by 640
Morphological Predictors of Restenosis After Coronary Stenting in Humans
Farb, A., Weber, D. K., Kolodgie, F. D., Burke, A. P., & Virmani, R. (2002) · Circulation · doi:10.1161/01.cir.0000019071.72887.bd · Cited by 593
Self-citationSirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction
Spaulding, C., Henry, P., Teiger, E., Beatt, K., Bramucci, E., Carrié, D., Slama, M. S., Merkely, B., Erglis, A., Margheri, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062006 · Cited by 564
Sianos, G., Papafaklis, M. I., Daemen, J., Vaina, S., van Mieghem, C. A., van Domburg, R. T., Michalis, L. K., & Serruys, P. W. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.059 · Cited by 493
Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans
Farb, A., Burke, A. P., Kolodgie, F. D., & Virmani, R. (2003) · Circulation · doi:10.1161/01.cir.0000091115.05480.b0 · Cited by 478
Self-citationPaclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention
Laarman, G. J., Suttorp, M. J., Dirksen, M. T., van Heerebeek, L., Kiemeneij, F., Slagboom, T., van der Wieken, L. R., Tijssen, J. G. P., Rensing, B. J., & Patterson, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062598 · Cited by 437
Kastrati, A., Dibra, A., Spaulding, C., Laarman, G. J., Menichelli, M., Valgimigli, M., Di Lorenzo, E., Kaiser, C., Tierala, I., Mehilli, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm402 · Cited by 373
Stent Thrombosis Redux — The FDA Perspective
Farb, A., & Boam, A. B. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068304 · Cited by 284
Doyle, B., Rihal, C. S., O’Sullivan, C. J., Lennon, R. J., Wiste, H. J., Bell, M., Bresnahan, J., & Holmes, D. R. (2007) · Circulation · doi:10.1161/circulationaha.107.707331 · Cited by 217
Cited by
Kolandaivelu, K., Swaminathan, R., Gibson, W. J., Kolachalama, V. B., Nguyen-Ehrenreich, K.-L., Giddings, V. L., Coleman, L., Wong, G. K., & Edelman, E. R. (2011) · Circulation · doi:10.1161/circulationaha.110.003210 · Cited by 802
Drug-Eluting Coronary-Artery Stents
Stefanini, G. G., & Holmes, D. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1210816 · Cited by 728
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Park, S.-J., Park, D.-W., Kim, Y.-H., Kang, S.-J., Lee, S.-W., Lee, C. W., Han, K.-H., Park, S.-W., Yun, S.-C., Lee, S.-G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001266 · Cited by 511
Otsuka, F., Vorpahl, M., Nakano, M., Foerst, J., Newell, J. B., Sakakura, K., Kutys, R., Ladich, E., Finn, A. V., Kolodgie, F. D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.001790 · Cited by 491
Self-citationOtsuka, F., Byrne, R. A., Yahagi, K., Mori, H., Ladich, E., Fowler, D. R., Kutys, R., Xhepa, E., Kastrati, A., Virmani, R., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv205 · Cited by 491
Self-citation
Metadata
- Authors
- Nakazawa, G., Finn, A. V., Joner, M., Ladich, E., Kutys, R., Mont, E. K., Gold, H. K., Burke, A. P., Kolodgie, F. D., & Virmani, R.
- Venue
- Circulation
- Published
- 2008-09-09
- Volume
- 118
- Issue
- 11
- Pages
- 1138-1145
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2057218988
- Cited by
- 611
- References
- 21
- FWCI
- 44.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.